Kexing Biopharm participated in CPHI Milan 2026, held from October 6 to 8, presenting its global innovative drug pipeline, biosimilars developed through collaborative partnerships, and a diverse range of medicines …
Aureka Biotechnologies announced the completion of a US$100 million Series B financing round on August 10, 2026. Granite Asia provided the first tranche as the sole investor, while a leading …
Kaigene, Inc., a U.S. biotechnology company focused on developing next-generation antibody therapies for autoimmune diseases, has announced an exclusive licensing partnership with Taisho Pharmaceutical Co., Ltd., one of Japan’s leading …
Micross Components, Inc. (“Micross”), a leading supplier of high-reliability microelectronics products and engineering services for the aerospace, defense, space, medical, and industrial sectors, has announced a definitive agreement to acquire …
AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) under the Asymchem Group (stock codes: 002821.SZ / 6821.HK), has announced the groundbreaking of a new research and development facility at …
Decoy Therapeutics Inc, a biotechnology company focused on developing Designable Multi-Antivirals (D-MAVs), has announced that one of its D-MAV candidates has demonstrated in vitro effectiveness against the wild-type Ebola Zaire …
Rescale, a digital engineering platform built for the AI era, has secured funding through the Genesis Mission, a U.S. Department of Energy (DOE) initiative designed to create the world’s most …
A growing school of thought within artificial intelligence suggests that the long-term competitive advantage in AI may no longer reside primarily in the models themselves. As advanced AI systems increasingly …
SetPoint Medical, a commercial-stage medical technology company focused on advancing treatment options for individuals with chronic autoimmune disorders, has announced the successful completion of the first implantation of the SetPoint …
At the 17th Annual Meeting of the New Champions (Summer Davos 2026), organized by the World Economic Forum in Dalian on June 23, Gong Yingying, Founder and Chairwoman of Yidu …
EndoDNA, a company specializing in precision health intelligence, has introduced BIOS, an innovative and patented clinical decision-support platform designed exclusively for licensed healthcare professionals. Replacing the company’s previous interpretation engine, …
Volta Labs, the company behind the Callisto Sample Prep System, has introduced its DNA Library Preparation Application designed for the Oxford Nanopore Technologies Ligation Sequencing Kit V14 (SQK-LSK114). Created through …
Vector Science & Therapeutics announced that it has signed a three-year development and manufacturing partnership with MPP Group LLC to produce pharmaceutical-grade peptides and manufacture Vector’s drug delivery devices. MPP …
The global pharmaceutical sector is entering a pivotal phase. Although the FDA Modernization Act 2.0 has opened the door for Non-Animal Models (NAMs), widespread adoption is still slowed by major …
Lakewood-Amedex Biotherapeutics Inc, a clinical-stage biotech firm focused on developing a new category of powerful, rapid-acting, broad-spectrum antimicrobials known as the Bisphosphocin® class, has announced the addition of Joseph Tucker, …
Arcera Life Sciences a global life sciences firm based in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co Ltd, an innovation-led international pharmaceutical and healthcare company, have announced the signing …
Intensity Therapeutics, Inc., a late-stage biotechnology firm, focuses on discovering and developing proprietary cancer treatments using its non-covalent drug-conjugation technology. This approach is designed to destroy tumors while enhancing the …
Mabwell (688062.SH), an innovation-focused biopharmaceutical company with an integrated value chain, has announced that the National Medical Products Administration (NMPA) has accepted the Investigational New Drug (IND) application for its …
Insilico Medicine, a clinical-stage biotechnology company specializing in generative artificial intelligence (AI) for drug discovery and development, has announced a strategic research partnership with ASKA Pharmaceutical Co., Ltd. (“ASKA”), a …
Vimgreen Pharmaceuticals, a prominent company focused on modulating adenosine signaling pathways, has announced that China’s Center for Drug Evaluation (CDE) has cleared its Investigational New Drug (IND) application for VG081821 …
HotSpot Therapeutics, Inc., a biotech firm focused on advancing oral, allosteric small-molecule therapies that engage natural regulatory pockets, has announced plans to share preclinical findings from its interferon regulatory factor …
Hyundai Bioscience has revealed an ambitious new plan aimed at addressing worldwide viral outbreaks, confirming the launch of its Phase 2 clinical trials in the United States. During its presentation …
We’re committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, …
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had …
Brii Biosciences Limited, a biotechnology company focused on developing treatments for diseases with significant unmet needs, announced its acquisition of intellectual property (IP) and other assets related to BRII-179 from …
CNH Industrial brand New Holland Agriculture is always on the lookout for bright young minds. One of the reasons they have partnered with VIVES Higher Education College of Applied Sciences …
